The Evaluation of Surrogate Laboratory Parameters for Predicting the Trend of Viral Loads in Patients with Severe Fever with Thrombocytopenia Syndrome: Cross-Correlation Analysis of Time Series
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background: There is a correlation between the severe fever with thrombocytopenia syndrome (SFTS) viral load and disease severity; however, measurement of viral load is difficult in general laboratory and it takes time to obtain a viral load value. Here, the laboratory parameters for predicting the dynamic changes in SFTS viral load were identified. In addition, we tried to evaluate a specific time point for the early determination of clinical deterioration using dynamic change of laboratory parameters. Materials and methods: This observational study included SFTS patients in Korea (2013 - 2020). Cross-correlation analysis at lagged values was used to determine the temporal correlation between the SFTS viral loads and time-series variables. Fifty-eight SFTS patients were included in the non-severe group (NSG) and 11 in the severe group (SG). Results: In the cross-sectional analyses, 10 parameters -white blood cell, absolute neutrophil cell, lymphocyte, platelet, activated partial thromboplastin time (aPTT), C-reactive protein, aspartate aminotransferase (AST), alanine transaminase (ALT), lactate dehydrogenase (LDH), and creatine phosphokinase (CPK)- were assessed within 30 days from the onset of symptoms; they exhibited three different correlation patterns: (1) positive, (2) positive with a time lag, and (3) negative. A prediction score system was developed for predicting SFTS fatality based on age and six laboratory variables -platelet, aPTT, AST, ALT, LDH, and CPK- in 5 days after the onset of symptoms; this scoring system had 87.5% sensitivity and 86.0% specificity (95% confidence interval: 0.831 - 1.00, P <0.001). Conclusion: Three types of correlation patterns between the dynamic changes in SFTS viral load and laboratory parameters were identified. The dynamic changes in the viral load could be predicted using the dynamic changes in these variables, which can be particularly helpful in clinical settings where viral load tests cannot be performed. Also, the proposed scoring system could provide timely treatment to critical patients by rapidly assessing their clinical course.
Abstract
Background: There is a correlation between the severe fever with thrombocytopenia syndrome (SFTS) viral load and disease severity; however, measurement of viral load is difficult in general laboratory and it takes time to obtain a viral load value. Here, the laboratory parameters for predicting the dynamic changes in SFTS viral load were identified. In addition, we tried to evaluate a specific time point for the early determination of clinical deterioration using dynamic change of laboratory parameters. Materials and methods: This observational study included SFTS patients in Korea (2013 - 2020). Cross-correlation analysis at lagged values was used to determine the temporal correlation between the SFTS viral loads and time-series variables. Fifty-eight SFTS patients were included in the non-severe group (NSG) and 11 in the severe group (SG). Results: In the cross-sectional analyses, 10 parameters -white blood cell, absolute neutrophil cell, lymphocyte, platelet, activated partial thromboplastin time (aPTT), C-reactive protein, aspartate aminotransferase (AST), alanine transaminase (ALT), lactate dehydrogenase (LDH), and creatine phosphokinase (CPK)- were assessed within 30 days from the onset of symptoms; they exhibited three different correlation patterns: (1) positive, (2) positive with a time lag, and (3) negative. A prediction score system was developed for predicting SFTS fatality based on age and six laboratory variables -platelet, aPTT, AST, ALT, LDH, and CPK- in 5 days after the onset of symptoms; this scoring system had 87.5% sensitivity and 86.0% specificity (95% confidence interval: 0.831 - 1.00, P <0.001). Conclusion: Three types of correlation patterns between the dynamic changes in SFTS viral load and laboratory parameters were identified. The dynamic changes in the viral load could be predicted using the dynamic changes in these variables, which can be particularly helpful in clinical settings where viral load tests cannot be performed. Also, the proposed scoring system could provide timely treatment to critical patients by rapidly assessing their clinical course.
참고문헌 (23)
- Kuhn JH, "2020 taxonomic update for phylum Negarnaviricota(Riboviria : Orthornavirae), including the large orders Bunyavirales and Mononegavirales", Arch Virol, 165, pp.3023~3072 (2020)
- 유정래, "Seroprevalence of Severe Fever with Thrombocytopenia Syndrome in the Agricultural Population of Jeju Island, Korea, 2015–2017", Infection and Chemotherapy, 51(4), pp.337~344 (2019), 대한감염학회[DOI]
- Yu XJ, "Fever with thrombocytopenia associated with a novel bunyavirus in China", N Engl J Med, 364, pp.1523~1532 (2011)
- Liu Y, "Person-to-person transmission of severe fever with thrombocytopenia syndrome virus", Vector Borne Zoonotic Dis, 12, pp.156~160 (2012)
- Zhang YZ, "Hemorrhagic fever caused by a novel Bunyavirus in China : pathogenesis and correlates of fatal outcome", Clin Infect Dis, 54, pp.527~533 (2012)
- Chen Y, "Risk factors associated with fatality of severe fever with thrombocytopenia syndrome : a meta-analysis", Oncotarget, 8, pp.89119~89129 (2017)
- Sun Y, "Host cytokine storm is associated with disease severity of severe fever with thrombocytopenia syndrome", J Infect Dis, 206, pp.1085~1094 (2012)
- Gai ZT, "Clinical progress and risk factors for death in severe fever with thrombocytopenia syndrome patients", J Infect Dis, 206, pp.1095~1102 (2012)
- Deng B, "Clinical features and factors associated with severity and fatality among patients with severe fever with thrombocytopenia syndrome Bunyavirus infection in Northeast China", PLoS One, 8, pp.e80802~ (2013)
- Wang F, "Risk factors and clinical characteristics of severe fever with thrombocytopenia syndrome", Int J Gen Med, 13, pp.1661~1667 (2020)
- Lu QB, "Characterization of immunological responses in patients with severe fever with thrombocytopenia syndrome : a cohort study in China", Vaccine, 33, pp.1250~1255 (2015)
- Li MM, "CD4 T cell loss and Th2 and Th17 bias are associated with the severity of severe fever with thrombocytopenia syndrome(SFTS)", Clin Immunol, 195, pp.8~17 (2018)
- Hosmer DW Jr, "Applied logistic regression" (2013), John Wiley &Sons
- Liu MM, "Meta-analysis of the clinical and laboratory parameters of SFTS patients in China", Virol J, 13, pp.198~ (2016)
- Liu J, "Dynamic changes of laboratory parameters and peripheral blood lymphocyte subsets in severe fever with thrombocytopenia syndrome patients", Int J Infect Dis, 58, pp.45~51 (2017)
- Sun L, "Detection and evaluation of immunofunction of patients with severe fever with thrombocytopenia syndrome", Clin Exp Med, 14, pp.389~395 (2014)
- Ding S, "Age is a critical risk factor for severe fever with thrombocytopenia syndrome", PLoS One, 9, pp.e111736~ (2014)
- Cui N, "Severe fever with thrombocytopenia syndrome bunyavirus-related human encephalitis", J Infect, 70, pp.52~59 (2015)
- 유정래, "Application of therapeutic plasma exchange in patients having severe fever with thrombocytopenia syndrome", The Korean Journal of Internal Medicine, 34(4), pp.902~909 (2019), 대한내과학회[DOI]
- Seo JW, "Clinical update of severe fever with thrombocytopenia syndrome", Viruses, 13, pp.1213~ (2021)
- 오원섭, "Effect of Early Plasma Exchange on Survival in Patients with Severe Fever with Thrombocytopenia Syndrome: A Multicenter Study", Yonsei Medical Journal, 58(4), pp.867~871 (2017), 연세대학교의과대학[DOI]
- Xiong S, "A simple and practical score model for predicting the mortality of severe fever with thrombocytopenia syndrome patients", Medicine(Baltimore), 95, pp.e5708~ (2016)
- Jia B, "A scoring model for predicting prognosis of patients with severe fever with thrombocytopenia syndrome", PLoS Negl Trop Dis, 11, pp.e0005909~ (2017)